SCHEMBL24011234

SCHEMBL24011234

COc1ccc(CNC(=O)NC2CCN(C(=O)c3cccc(S(C)(=O)=O)c3)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ MCHR1 Q99705 3/20 0.52
▸ HRH3 Q9Y5N1 1/20 0.52
▸ HRH1 P35367 1/20 0.47
▸ CCR3 P51677 1/20 0.47
▸ SIRT5 Q9NXA8 1/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ PRKAA2 P54646 3/20 0.46
▸ PRKAB2 O43741 1/20 0.46
▸ PRKAG1 P54619 1/20 0.46
▸ PRKAA1 Q13131 1/20 0.46
▸ PRKAG3 Q9UGI9 1/20 0.46
▸ PRKAG2 Q9UGJ0 1/20 0.46
▸ PRKAB1 Q9Y478 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011203 0.89 NPC1 (0.60) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL26633674 0.88 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011333 0.87 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011194 0.87 MCHR1 (0.60) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011230 0.87 EPHX2 (0.61) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011324 0.86 NPC1 (0.55) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011089 0.86 NPC1 (0.57) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011198 0.85 NPC1 (0.64) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011202 0.85 NPC1 (0.54) NPC1RAB9ASMN1; SMN2MCHR1HRH3
SCHEMBL24011091 0.84 NPC1 (0.55) NPC1RAB9ASMN1; SMN2MCHR1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
WO-2021226276-A2 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT NPC1 128/4885RAB9A 814/4885SMN1; SMN2 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback